2011 Annual Meeting | Controversial Issues in Neurologic Infections

��ɫ��

2011 Annual Meeting | Controversial Issues in Neurologic Infections

Date Saturday 03/23/13

Time 06:30 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Israel Steiner, MD

Topic(s)

Learning Objectives Participants should understand the complexities in determining the underlying infectious etiology of neurologic disorders through the discussion of two common disorders, multiple sclerosis and chronic fatigue syndrome, the considerations associated with prescribing effective agents that carry heavy side effects; and learn the pros and cons of current recommendations for the therapy of steroids in herpes simplex encephalitis. The interactive format will highlight the uncertainties and controversial issues in this important realm.

CME Available No CME available

Core Competencies Medical Knowledge

Recommended Audience General Neurologist, Specialist Neurologist

Teaching Styles Interactive, Audience Participation

Event Timeline
06:30 AM - 07:10 AM		Steroid Treatment in Herpes Simplex Encephalitis Avindra Nath, MD, MBBS, FAAN, Israel Steiner, MD
06:30 AM - 08:30 AM		Break
07:10 AM - 07:50 AM		Is There An Infectious Etiology for Multiple Sclerosis? Avindra Nath, MD, MBBS, FAAN, Andrew R. Pachner, MD
07:50 AM - 08:30 AM		Natalizumab Is Not Too Risky To Be Used in Multiple Sclerosis Andrew R. Pachner, MD, Israel Steiner, MD

Faculty Disclosures
Israel Steiner, MD	No disclosure on file
Avindra Nath, MD, MBBS, FAAN	Dr. Nath has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from ALS Association. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Andrew R. Pachner, MD	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��